Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies. - Wikidata - awgldk - TriplyDB

Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.

Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.

http://www.wikidata.org/entity/Q37699097

about

Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.Acute kidney injury.Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.Acute kidney injury, renal function, and the elderly obese surgical patient: a matched case-control study.Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.Evaluation of ITA Graft Function Using CT Angiography.Drug-Induced Kidney Injury in the Elderly.Co-metabolic degradation of iomeprol by a Pseudomonas sp. and its application in biological aerated filter systems.Progression to stage 3 and 4 chronic kidney disease and risk factor stratification following endovascular aortic aneurysm repair.Diastolic dysfunction and contrast-induced nephropathy in patients undergoing coronary angiography.Contrast induced nephropathy; recent findings.The Protective Effects of Enalapril Maleate and Folic Acid Tablets against Contrast-Induced Nephropathy in Diabetic Rats.

P2860

Q34119573-AAA79A24-8080-4827-9ED0-CCFE83F5C480 Q34455487-87AD4AB2-128B-403B-B13B-1620FCB12411 Q34884784-0876704F-0F53-4E21-B15D-DDD98347C064 Q35999430-0A538C21-9D2E-44ED-82CC-AF1D076774E9 Q37597349-11BBE6D6-DB19-428B-A630-77461B5AB409 Q37826019-EF03BFDA-BB6B-4270-92D1-7F4936DE09DC Q41199362-C1ABF9B4-A97A-4FD8-9F5E-4F3E7B537CA6 Q45065480-53E6A23D-DF27-4C2A-8871-074416CA1842 Q47272844-D21B318B-EB0D-4DB8-A00D-FCE9FDD870A0 Q48037281-B30EDC13-262C-48B7-B5BA-D6F1745AB015 Q51006628-47C1323C-8593-49AD-A88D-11E91E0E9EE8 Q51801225-8CAE1092-C12A-4110-8EAC-327D1ED2A1D4 Q52725321-79270ED1-4A49-4ACC-9F7B-41BF28B54E1A

P2860

Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.

http://www.wikidata.org/entity/Q37699097

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Contrast-induced kidney injury ...... s and prophylactic strategies.

@en

Contrast-induced kidney injury ...... s and prophylactic strategies.

@nl

type

label

Contrast-induced kidney injury ...... s and prophylactic strategies.

@en

Contrast-induced kidney injury ...... s and prophylactic strategies.

@nl

prefLabel

Contrast-induced kidney injury ...... s and prophylactic strategies.

@en

Contrast-induced kidney injury ...... s and prophylactic strategies.

@nl

P1433

Q37699097-BDAA682B-613B-4D59-B4EC-A562ACD70836

P1476

Q37699097-AB87245C-DACC-4C89-A1D9-A40B3BE04551

P2093

Q37699097-71A94433-34C4-421F-AA93-5835C300E1DD

Q37699097-727E159E-A6E7-44A6-A34F-4F1DAE700467

P2860

Q37699097-06DFB029-667B-461D-9731-E861AC68A324

Q37699097-15663456-B688-4EF9-8665-45EEADB5D4DE

Q37699097-1660E428-B8FE-4B54-85DF-24E2319E9521

Q37699097-183EB74C-AF14-488B-AE9C-F03C36CD95D9

Q37699097-1930D5B8-ACF1-4B67-825B-6BEA2F5399B0

Q37699097-372C1486-1A99-4D81-B347-CCA2B417B03E

Q37699097-422A0437-BA8E-4A49-AF49-DA9577C7830C

Q37699097-488A952E-E2FA-4CF8-AF50-1EF994DE9174

Q37699097-48DE52F4-6E8D-4E18-B92B-C68754D19DD4

Q37699097-50D08452-9094-4F71-8DF2-8BDE90B577D2

P304

Q37699097-CDDAF069-5DCD-40B5-A2A3-F1479A6F1DAA

P31

Q37699097-1F419CC3-D97D-43B8-B004-27991C5528CD

P356

Q37699097-AD39AB36-EC5B-4471-9104-C7B064F07BBB

P433

Q37699097-F72C1B15-043A-4D2E-BD6B-D1171D6E6E86

P478

Q37699097-6E9AB506-F20A-4811-A63C-E203F4283366

P577

Q37699097-088D96F8-C00D-41CA-B0F8-21188920434D

P5875

Q37699097-15B1BF54-10E7-473E-BD7A-F997A45F6E05

P698

Q37699097-4609EF5B-6E20-4195-8E30-F1D047A2D396

P932

Q37699097-6EE72BF9-A5C9-4E7A-9CFE-820E39FCDDF7

P356

P1433

Clinical Cardiology

P1476

Contrast-induced kidney injury ...... rs and prophylactic strategies

@en

P2093

Anna Kagan

http://www.w3.org/2001/XMLSchema#string

David Sheikh-Hamad

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.

Hospital-acquired renal insufficiency.

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

Epidemiology and prognostic implications of contrast-induced nephropathy.

Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.

N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.

Pathophysiology of contrast-induced nephropathy.

Risk prediction of contrast-induced nephropathy.

P304

62-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.20687

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41579637

http://www.w3.org/2001/XMLSchema#string

P698

20186983

http://www.w3.org/2001/XMLSchema#string

P932

6653592

http://www.w3.org/2001/XMLSchema#string